Showing results (41-50 of 101) with videos related to
Sort By:
Pageof 11
Annals of Palliative Medicine|September 9, 2021
Resistance and aerobic exercise intervention during chemotherapy in patients with metastatic cancer: a pilot study in South KoreaJoo-Hwan Park, Ki Deok Park, Jin-Hong Kim, et al.Oncology Reports|September 19, 2018
C16‑ceramide and sphingosine 1‑phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulationMin Hee Kim, Joo-Won Park, Eun-Ji Lee, et al.Cancer Research and Treatment|December 1, 2023
Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tract and the Prognostic Significance of the Tumor Immune MicroenvironmentJaewon Hyung, Hyung-Don Kim, Gi Hwan Kim, et al.Clinical Genitourinary Cancer|April 5, 2024
Effectiveness of Adjuvant Chemotherapy in Variant Histology Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Stabilized Inverse Probability Treatment Weighting Analysis of Single Center ExperienceInkeun Park, Jungyo Suh, Bumjin Lim, et al.Journal of Cancer Research and Clinical Oncology|April 23, 2014
Active surveillance for metastatic or recurrent renal cell carcinomaInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.Medical Oncology (Northwood, London, England)|March 31, 2012
Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKIKwonoh Park, Jae-Lyun Lee, Inkeun Park, et al.Investigational New Drugs|May 29, 2013
Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancerChanghoon Yoo, Min-Hee Ryu, Young-Soon Na, et al.Anticancer Research|August 28, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based ChemotherapyJwa Hoon Kim, Changhoon Yoo, Hyehyun Jeong, et al.Cancer Chemotherapy and Pharmacology|December 9, 2016
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomasYoung Saing Kim, Sung Yong Oh, Se-Il Go, et al.Cancer Research and Treatment|December 30, 2014
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case ReportHyun Sun Woo, Kyoung Hwa Lee, Phill Hoon Yoon, et al.Pageof 11